资讯

Amneal Pharmaceuticals announces U.S. launch of Boruzu
Amneal Pharmaceuticals (AMRX) announced the U.S. launch of Boruzu, a new presentation of bortezomib for ready-to-use subcutaneous ...
Business Wire1 个月
Amneal’s BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, and mAbxience ...
Morningstar7 天
Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and ...
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, and Shilpa Medicare Limited (“Shilpa”) today announced the U.S. launch of ...